PDF(Pubmed)
Abstract：
Thrombotic events in SARS-COV-2 disease patients are frequent, especially in patients with comorbidities such as heart failure, hypertension, cancer, diabetes mellitus, kidney failure, vascular disease, and other pulmonary illnesses. In severe cases, in particular those of hospitalized patients with other comorbidities, the development of thrombotic events in spite of anticoagulation therapy has been observed. The main thrombotic events are pulmonary thromboembolism, cerebral ischemic stroke, and peripheral artery thrombosis. Despite the severity of SARS-COV-2 disease, some patients with the aforementioned comorbidities develop thrombotic events regardless of the severity of their SARS-COV-2 infection. In this setting, the cerebellum makes no exception as an uncommon, but still possible target for thrombotic events.
摘要：
SARS-COV-2病患者的血栓事件频繁发生，尤其是患有心力衰竭等合并症的患者，高血压,癌症,糖尿病,肾衰竭,血管疾病,和其他肺部疾病。在严重的情况下,特别是那些有其他合并症的住院患者，尽管有抗凝治疗,但仍观察到血栓事件的发生.主要的血栓事件是肺血栓栓塞,缺血性脑中风，和外周动脉血栓形成。尽管SARS-COV-2病情严重,与SARS-COV-2感染的严重程度无关,一些有上述合并症的患者会发生血栓事件.在此设置中，小脑也不例外，但仍可能是血栓事件的目标。
